Press release
Global AI-based Clinical Trial Solution Providers Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030
Request for Sample Pages: https://www.insightaceanalytic.com/report/global-ai-based-clinical-trial-solution-providers-market-/1082
According to the most recent research by InsightAce Analytic, the global AI-based clinical trial solution providers market market is expected to gain market share at a rapid pace during a forecast period. By region, North America is expected to dominate the market.
Artificial intelligence plays an essential role in clinical trials protocol and research. AI-based platforms facilitate the interpretability of clinical data and help solve the enormous and complex challenges of clinical research and the medical product development process. With AI platforms, researchers can study new molecules and therapies in silico.
Factors such as the advanced digital and medical technologies, rapid innovations of new AI-based platforms/systems, high prevalence of chronic & infectious diseases, increased healthcare expenditure, rising government investments for R&D of clinical trials, surging use of AI & machine learning techniques, and rising awareness among researchers regarding the AI platforms are projected to enhance the market growth during the forecast years. Additionally, the biopharmaceutical companies drive growth in the AI-based clinical trial solution providers market as most of these companies prefer using AI platforms and advanced planning & designing techniques to accelerate clinical trials.
However, the strict regulations related to AI-based clinical trial approvals and the poor knowledge of AI applications or platforms are expected to trim the market growth opportunities during the forecast period (2020-2030).
Geographically, North America has dominated the AI-based clinical trial solution providers market in 2020 and will continue to dominate over the estimated timeframe followed by Europe, owing to the rising human health diseases, fast adoption of new techniques, and the increasing clinical R&D funding by the government. Asia-Pacific region is anticipated to boom this market in the next few years due to the rising clinical trials and increasing investments in the research field.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-ai-based-clinical-trial-solution-providers-market-/1082
Major market players operating in the AI-based clinical trial solution providers market include Antidote Technologies, Inc. (US), AiCure, LLC (US), Deep 6 AI (US), Deep Lens Inc. (US), Innoplexus (Germany), Intelligencia.ai (US), MEDIAN Technologies (France), Mendel.ai (US), Phesi (US), Saama Technologies (US), Unlearn.AI, Inc. (US), and Trials.ai (US), among others.
A few of the developments in the market are as follows:
• In October 2021, Deep Lens (US) collaborated with Southern Oncology Specialists to use the AI-based solution VIPER for improving clinical trial matching. This partnership brings more precision medicine trials to the practice and broadens the practice’s existing research program.
• In September 2021, Deep 6 AI (US), the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), introduced Deep 6 for Life Sciences, a novel suite of AI software solutions for life science sponsors and CROs, built on its industry-leading clinical trial acceleration platform. Deep 6 for Life Sciences brings a new level of data-driven precision and insight to sponsors’ interventional and observational studies, saving them months and significantly de-risking their research efforts.
• In March 2020, Innoplexus AG (Germany) opened its proprietary Ontosight® AI search platform freely available to all medical researchers worldwide to help fight the COVID-19 pandemic.
Inquiring about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/report/global-ai-based-clinical-trial-solution-providers-market-/1082
Market Segments
Global AI-based Clinical Trial Solution Providers Market, by Target Therapeutic Area, 2020-2030 (Value US$ Mn)
• Cardiovascular Disorders
• CNS Disorders
• Infectious Disorders
• Metabolic Disorders
• Oncological Disorders
• Other Disorders
Global AI-based Clinical Trial Solution Providers Market, by Trial Phase, 2020-2030 (Value US$ Mn)
• Early Phase 1
• Phase 1
• Phase 2
• Phase 3
• Phase 4
Global AI-based Clinical Trial Solution Providers Market, by End-Users, 2020-2030 (Value US$ Mn)
• Pharmaceutical Companies
• Academia and Other Users
Global AI-based Clinical Trial Solution Providers Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a complete analysis of the prospects for global AI-based clinical trial solution providers market
To receive an industry overview and future trends of AI-based clinical trial solution providers market
To analyze the AI-based clinical trial solution providers market drivers and challenges
To get information on the AI-based clinical trial solution providers market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the AI-based clinical trial solution providers market industry
For More Information @ https://www.insightaceanalytic.com/report/global-ai-based-clinical-trial-solution-providers-market-/1082
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
To receive a comprehensive analysis of the prospects for Global Dialysis Equipment Market
To receive industry overview and future trends Dialysis Equipment Market
To analyse the Dialysis Equipment Market drivers and challenges
To get information on Dialysis Equipment market size value and volume (US$ Mn) forecast till 2028
Major Investments, Mergers & Acquisition in Dialysis Equipment Market industry
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global AI-based Clinical Trial Solution Providers Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030 here
News-ID: 2490321 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
